206 related articles for article (PubMed ID: 22693244)
1. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
Ahn HK; Lee S; Park YH; Sohn JH; Jo JC; Ahn JH; Jung KH; Park S; Cho EY; Lee JI; Park W; Choi DH; Huh SJ; Ahn JS; Kim SB; Im YH
Neuro Oncol; 2012 Aug; 14(8):1105-13. PubMed ID: 22693244
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
3. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
[TBL] [Abstract][Full Text] [Related]
4. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
[TBL] [Abstract][Full Text] [Related]
5. External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.
Genre L; Roché H; Varela L; Kanoun D; Ouali M; Filleron T; Dalenc F
Eur J Cancer; 2017 Feb; 72():200-209. PubMed ID: 28042991
[TBL] [Abstract][Full Text] [Related]
6. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
7. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
[TBL] [Abstract][Full Text] [Related]
8. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
9. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
[TBL] [Abstract][Full Text] [Related]
10. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
Marko NF; Xu Z; Gao T; Kattan MW; Weil RJ
Cancer; 2012 Aug; 118(15):3749-57. PubMed ID: 22180078
[TBL] [Abstract][Full Text] [Related]
11. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
12. Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases.
Fabregat-Franco C; Stradella A; Navarro V; Linares J; Galdeano M; Recalde S; Velasco R; Simo M; Fernadez A; Venthecourt AC; Falo C; Vazquez S; Bergamino M; Villanueva R; Pernas S; Gil-Gil MJ
Clin Transl Oncol; 2021 Sep; 23(9):1761-1768. PubMed ID: 33704689
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Nam JH; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast; 2020 Feb; 49():41-47. PubMed ID: 31677532
[TBL] [Abstract][Full Text] [Related]
14. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
15. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
[TBL] [Abstract][Full Text] [Related]
16. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
Huang Z; Zhou X; Tong Y; Zhu L; Zhao R; Huang X
BMC Cancer; 2021 Mar; 21(1):222. PubMed ID: 33663462
[TBL] [Abstract][Full Text] [Related]
17. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
19. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
[TBL] [Abstract][Full Text] [Related]
20. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
Wang J; Chen L; Nie Y; Wu W; Yao Y
Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
